Cutaneous Changes during Prolonged Application of 12-0-Tetradecanoylphorbol-13-acetate on Mouse Skin and Residual Effects after Cessation of Treatment

Medicine and Dentistry

• Therapeutic Procedure 100%
• Hair Follicle 62%
• Hyperplasia 37%
• Epidermis 37%
• Papilloma 25%
• Epidermis Hyperplasia 25%
• Mast Cell 25%
• Tissues 25%
• Skin 25%
• Keratinocyte 25%
• Neoplasm 12%
• Carcinogenesis 12%
• Steady State 12%
• Cell Type 12%
• Serositis 12%
• Capillary 12%
• Thymidine 12%
• Cell Population 12%
• Morphometrics 12%
• Carcinoma 12%
• Edema 12%
• Basement Membrane 12%
• Target Cell 12%
• Basal Cell 12%
• Tumor Promoter 12%
• Chronic Inflammation 12%
• Chronic Drug Administration 12%
• Cell Damage 12%
• Tachyphylaxis 12%
• Topical Drug Administration 12%
• Tritium 12%
• Cell Kinetics 12%
• Growth 12%
• Pulse Rate 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Hyperplasia 37%
• Potassium Acetate 25%
• Papilloma 25%
• Mouse 25%
• Epidermis Hyperplasia 25%
• Animal 25%
• Neoplasm 12%
• Carcinogenesis 12%
• Thymidine 12%
• Inflammation 12%
• Tumor Promoter 12%
• Carcinoma 12%
• Edema 12%
• Tachyphylaxis 12%
• Tritium 12%
• Chronic Inflammation 12%

Veterinary Science and Veterinary Medicine

• Dermis 37%
• Mast Cell 25%
• Target Cell 12%
• Dark Cell 12%